We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 99.07 | 19 | 09:56:48 |
From May 2019 to May 2024
LONDON--Pharmaceutical company Vectura Group PLC (VEC.LN) said Thursday that it will receive milestone payments totaling $20 million from Novartis (NOVN.VX), following the decision by U.S. Food and Drug Administration to accept two new drug applications made by Novartis.
The regulatory has accepted Novartis' new drug applications for QVA149 and NVA237 for the long-term maintenance treatment of chronic obstructive pulmonary disease. The acceptances have triggered milestone payments to Vectura of $12.5 million and $7.5 million, respectively.
Shares of Vectura at 1119 GMT trading 1.2%, at 151 pence.
Write to Tapan Panchal at tapan.panchal@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
